Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$542.50 -6.54 (-1.19%)
At close: Nov 5, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Income After Tax (2009 - 2026)

Updated

Vertex Pharmaceuticals' Income After Tax came in at $653.6 million for Q3 2026, down 39.6% from $1.08 billion a year earlier and down 40.6% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Income After Tax (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Vertex Pharmaceuticals reported Income After Tax of $3.98 billion, up 8.2% year-over-year; for FY2025, it was $3.95 billion.

  • Income After Tax carries a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • Going back by year, Income After Tax was -$535.6 million in FY2024, $3.62 billion in FY2023 (+9.0%), $3.32 billion in FY2022 (+41.8%) and $2.34 billion in FY2021 (-13.6%).
  • The Q3 2026 figure represents the lowest quarterly Income After Tax since Q1 2025.
  • Year-over-year, Income After Tax increased in four of the last seven quarters, with growth averaging 1.9%.
  • The fastest year-over-year change in Income After Tax over five years came in Q1 2026 (growth of 59.6%), and the weakest in Q1 2025 (a decline of 41.2%).
  • Business Quant data shows VRTX's Income After Tax at $1.1 billion (Q2 2026), $1.03 billion (Q1 2026) and $1.19 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,286.35 Bn 1,259.96 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 655.58 Bn 575.44 Bn 17.30 Bn 210.00 Mn
3 AbbVie 509.44 Bn 477.50 Bn 13.12 Bn 4.22 Bn
4 Merck 362.14 Bn 325.14 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 309.04 Bn 282.62 Bn - -
6 Astrazeneca 289.57 Bn 263.55 Bn 13.26 Bn 4.80 Bn
7 Amgen 248.97 Bn 200.62 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.95 Bn 182.98 Bn 6.73 Bn 2.43 Bn
9 Pfizer 170.25 Bn 117.91 Bn 12.56 Bn 3.25 Bn
10 Vertex Pharmaceuticals 137.54 Bn 109.53 Bn 2.91 Bn 653.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 653.60 Mn
Jun 30, 2026 1.10 Bn
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.19 Bn
Sep 30, 2025 1.08 Bn
Jun 30, 2025 1.03 Bn
Mar 31, 2025 646.30 Mn
Dec 31, 2024 913.00 Mn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 -3.59 Bn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 968.80 Mn
Sep 30, 2023 1.04 Bn
Jun 30, 2023 915.70 Mn
Mar 31, 2023 699.80 Mn
Dec 31, 2022 818.90 Mn
Sep 30, 2022 930.50 Mn
Jun 30, 2022 810.50 Mn
Mar 31, 2022 762.10 Mn
Dec 31, 2021 770.10 Mn
API Access

Vertex Pharmaceuticals Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=VRTX&period=max&api_key=YOUR_API_KEY